Equity Details
Price & Market Data
Price: $54.00
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $3,858,308,608
Daily Volume: 0
Performance Metrics
1 Week: 19.10%
1 Month: 18.11%
3 Months: -15.72%
6 Months: -30.46%
1 Year: -16.12%
YTD: -25.19%
About Zealand Pharma A/S (ZLDPF)
Detailed market insights for Zealand Pharma A/S (ZLDPF). Current price: 54.00, daily change: $0.00 / 0.00%. Market cap: 3,858,308,608. YTD, 1-week, 1-month performance are highlighted.
Company Details
Employees: 481
Sector: Health technology
Industry: Biotechnology
Country: Denmark
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.